Epilepsy Foundation of Metropolitan New York

EFMNY is pleased to announce our Community Epilepsy Awareness & Education Webinar Series is continuing into 2021 beginning this Wednesday, January 13 at 6:30PM. The series is titled "Seizure Recognition & First Aid" and we ask that you kindly register in advance for this Zoom webinar: https://us02web.zoom.us//tZcsce2grTMpG9MwXUWiWR6a1FYQfsgRh... After registering, you will receive a confirmation email containing information about joining the meeting. Please join us! #Epilepsy101

According to media reports, the long-awaited game Cyberpunk 2077 (CD Projekt) contains several scenes with excessive strobe/flashing lights and sustained animated imagery that may affect those with photosensitive epilepsy. For those with photosensitive epilepsy or are simply sensitive to flashing lights and are planning to play the game once it is released on Dec. 10, please be advised that the strobe lights may trigger seizures in some people. Read more: https://www.epilepsy.com//epilepsy-foundation-advises-caut

Seizure Clusters: Unmet Needs & Emerging Formulations [Webinar] #epilepsyawareness #aquestive #EFMNY https://youtu.be/0wwVf6vA8Mo

PREVENTING BREAKTHROUGH SEIZURES: You Can Do More Than You Think [Webinar] #epilepsyawareness #Eisai #EFMNY https://youtu.be/xSIuqmxhIUE

Neurelis News! VALTOCO is now available in pharmacies nationwide! #epilepsyawareness #neurelis #valtoco https://www.neurelis.com//neurelis-announces-national-whol

The Epilepsy Foundation of Metropolitan New York, a proud regional affiliate of the Epilepsy Foundation of America (EFA - Landover, MD), is pleased to have Neurelis, Inc. as a National Sponsor for its Virtual 9th Annual Walk to End Epilepsy in New York City, with the Zoom Call Day on Sunday, October 18, 2020. #VirtualWalktoEndEpilepsy #epilepsyawareness #neurelis

Greenwich Biosciences is pleased to announce 8/4/20 that EPIDIOLEX (cannabidiol) is now approved for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients 1 year of age and older. This approval follows a clinical study that showed significant reductions in the frequency of TSC-associated seizures. See the EPIDIOLEX full Prescribing Information here: https://ir.gwpharm.com//fda-approves-epidiolexr-cannabidio

*Meeting the Needs of the Epilepsy Community - SK Life Science Inc.* https://www.xcopri.com/patient-stories/